Incidence of New-onset Diabetes Mellitus after COVID-19 Infection in Bangchak Hospital

Completed

• Conditions: new-onset diabetes after COVID-19 infection; diabetes, steroids, coronavirus disease, COVID-19

• Registration Number: TCTR20240425002
• Lead Sponsor: Bangchak Hospital

Brief Summary

The incidence of new-onset diabetes was 63 cases (10.5%) while non-diabetes patients were 538 cases (89.5%). Factors affecting the incidence of diabetes include receiving steroids, receiving steroids for more than 14 days, length of stay for a hospitalization for more than 14 days, high initial random plasma glucose level, and high serum creatinine, especially among patients receiving steroids. These factors were found to be related to diabetes with a statistical significance.

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-12-31
• Study Start: 2024-04-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 601

Inclusion Criteria

1. Diagnosed COVID-19 infection
2. Age more than 18 years-old
3. History of In-hospital patient
4. There was blood tested for the fasting plasma glucose or HbA1c level within 3 months after infection

Exclusion Criteria

1. Diabetes patients
2. Initial fasting plasma glucose(FPG) more than 126 mg/dl or random plasma glucose more than 200 mg/dl or hemoglobinA1c more than 6.5%

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of new-onset diabetes 3 month after COVID-19 infection fasting blood glucose or hemoglobinA1c

Secondary Outcome Measures

Name	Time	Method
risk factor for diabetes During COVID-19 infection clinical characteristic